Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Vermont Tech Scene.
Press releases published on May 29, 2025
La solución de núcleo de paquete convergente de Mavenir está lista para transformar la red móvil global 4G/5G de Tampnet
GlobeNewswire
·
May 29, 2025
READING, Reino Unido, May 29, 2025 (GLOBE NEWSWIRE) -- Mavenir, el proveedor de infraestructura de red nativa en la nube, anunció hoy que fue seleccionado como socio tecnológico clave por Tampnet, un líder mundial en conectividad y servicios de red …
FioBit’s 2025 Dogecoin Cloud Mining Guide: Securely Invest in DOGE Without Hardware Using Trusted Cryptocurrency Mining Providers
GlobeNewswire
·
May 29, 2025
Sydney, Austrailia, May 29, 2025 (GLOBE NEWSWIRE) -- According to the latest data from CoinDesk as of May 2025, Dogecoin (DOGE) has rebounded from a recent low of $0.2196 to $0.2285, indicating a market recovery. With trading volume surging to 393 million …
Spirit Blockchain Capital Reports Q1 2025 Operational and Financial Highlights
GlobeNewswire
·
May 29, 2025
Vancouver, BC , May 29, 2025 (GLOBE NEWSWIRE) -- Spirit Blockchain Capital Inc. (CSE: SPIR) (“Spirit” or the “Company”), a publicly listed investment company focused on blockchain infrastructure and digital asset yield opportunities, is pleased to announce …
XRP, DOGE holders turn to APTMiner platform to earn passive income
GlobeNewswire
·
May 29, 2025
Seattle, Washington , May 29, 2025 (GLOBE NEWSWIRE) -- Friends of Dogecoin and Ripple start using APT Miner to earn passive income Recently, the price of coins has fluctuated greatly. Many friends who hold Dogecoin and Ripple do not want to pay attention …
MediPharm Labs Responds to Fabricated Allegations from Dissident Shareholder
GlobeNewswire
·
May 29, 2025
TORONTO, May 29, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE:MLZ) (“MediPharm” or the “Company”), a pharmaceutical company specialized in precision-based cannabinoids, today confirmed that the Company is aware of the news …
Kane Biotech Announces First Quarter 2025 Financial Results
GlobeNewswire
·
May 29, 2025
WINNIPEG, Manitoba, May 29, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech”, “Kane” or the “Company”) today announces its first quarter 2025 financial results. First Quarter 2025 Financial Highlights (Comparatives Exclude …
NVIDIA Announces Upcoming Events for Financial Community
GlobeNewswire
·
May 29, 2025
SANTA CLARA, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- NVIDIA will present at the following events for the financial community: BofA Securities 2025 Global Technology Conference Wednesday, June 4, 7:50 a.m. Pacific time Nasdaq Investor Conference in …
Cytek® Biosciences Is Setting the New Standard for Full Spectrum Flow Cytometry with the New Cytek Aurora™ Evo Flow Cytometer
GlobeNewswire
·
May 29, 2025
FREMONT, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- In a move that underscores its dedication to shaping the future of cell analysis, Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced the launch of the Cytek Aurora™ Evo system, a new full spectrum flow …
Tarsus to Participate in Upcoming Investor Conferences
GlobeNewswire
·
May 29, 2025
IRVINE, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management plans to participate in the following upcoming investor conferences: William Blair 45th Annual Growth Stock Conference on Tuesday, …
Cycurion, Inc. Receives Expected Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q
GlobeNewswire
·
May 29, 2025
MCLEAN, Va., May 29, 2025 (GLOBE NEWSWIRE) -- Cycurion, Inc. (Nasdaq: CYCU) ("Cycurion" or the "Company"), a trusted leader in IT cybersecurity solutions and AI, today announced that it received an expected deficiency notification letter from the Listing …
New Data at ASCO 2025 Affirms DecisionDx®-Melanoma's Ability to Improve Upon Staging-Based Risk Stratification and Predict Survival Outcomes
GlobeNewswire
·
May 29, 2025
FRIENDSWOOD, Texas, May 29, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, will present novel research aimed at enhancing the clinical management of patients …
Blaize to Attend D.A. Davidson 1st Annual Consumer & Technology Conference
GlobeNewswire
·
May 29, 2025
EL DORADO HILLS, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Blaize Holdings, Inc. (NASDAQ: BZAI), a pioneer in scalable, energy-efficient AI computing across edge to cloud, today announced it will participate in the upcoming D.A. Davidson 1st Annual Consumer …
RIB Software Launches Global Customer Campaign: “You See It. Together, We’ll See It Through”
GlobeNewswire
·
May 29, 2025
Stuttgart, Germany, May 29, 2025 (GLOBE NEWSWIRE) -- Stuttgart, Germany – May 2025 – RIB Software, a global leader in engineering and construction software technology, today announced the launch of its latest global brand campaign: “You See It. Together, …
Alumis to Present at the Jefferies Global Healthcare Investor Conference
GlobeNewswire
·
May 29, 2025
SOUTH SAN FRANCISCO, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a late-stage biopharma company developing next-generation targeted therapies for patients with immune-mediated diseases, today announced that Martin Babler, President …
Microchip Technology Raises Financial Guidance for Sales and EPS for First Quarter of Fiscal Year 2026
GlobeNewswire
·
May 29, 2025
CHANDLER, Ariz., May 29, 2025 (GLOBE NEWSWIRE) -- Microchip Technology Incorporated, a leading provider of smart, connected, and secure embedded control solutions, today updated the range of its prior guidance for net Sales and GAAP and non-GAAP earnings …
Fulcrum Therapeutics to Present at Upcoming Medical Meetings
GlobeNewswire
·
May 29, 2025
CAMBRIDGE, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare …
Kevin Rubin Joins Zscaler as Chief Financial Officer to Drive Continued Growth
GlobeNewswire
·
May 29, 2025
SAN JOSE, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Zscaler, Inc. (NASDAQ: ZS), the leader in cloud security, today announced the appointment of Kevin Rubin as Chief Financial Officer. In his role, Rubin will oversee Zscaler’s global finance organization …
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in June
GlobeNewswire
·
May 29, 2025
CAMBRIDGE, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, today …
NextCure and LigaChemBio to Present Trial in Progress Poster for LNCB74, a B7-H4 Targeted Antibody-Drug Conjugate, as Monotherapy in Participants with Advanced Solid Tumors at ASCO 2025
GlobeNewswire
·
May 29, 2025
LNCB74 is in a Phase 1, open-label, first-in-human study that will include dose escalation, safety, and biomarker backfills and randomized dose expansion/optimization The study is currently enrolling in dose escalation Poster to be presented June 2, 2025, …
Vaxart to Participate at the Jefferies Global Healthcare Conference on June 5, 2025
GlobeNewswire
·
May 29, 2025
SOUTH SAN FRANCISCO, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, today announced that members …